Global X China Biotech Innovation ETF (CHB) Short Interest Ratio & Short Volume

Short interest is the volume of Global X China Biotech Innovation ETF shares that have been sold short but have not yet been closed out or covered. As of January 31st, investors have sold 8,800 shares of CHB short. Learn More on Global X China Biotech Innovation ETF's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CHB shares currently have a short interest ratio of 7.0. Learn More on Global X China Biotech Innovation ETF's short interest ratio.

Global X China Biotech Innovation ETF saw a increase in short interest in January. As of January 31st, there was short interest totaling 8,800 shares, an increase of 1,660.0% from the previous total of 500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies compare to Global X China Biotech Innovation ETF: VanEck Green Infrastructure ETF (73.50%), First Trust Indxx Metaverse ETF (2.40%), Pacer BlueStar Engineering the Future ETF (1.00%), Pacer BlueStar Digital Entertainment ETF (0.25%), SPDR MSCI USA Climate Paris Aligned ETF (0.75%), Global X Green Building ETF (1.10%), Global X Wind Energy ETF (119.10%), SoFi Web 3 ETF (0.08%), Global X Metaverse ETF (0.30%), Kelly CRISPR & Gene Editing Technology ETF (2.37%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks.

Short selling CHB is an investing strategy that aims to generate trading profit from Global X China Biotech Innovation ETF as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Global X China Biotech Innovation ETF occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CHB, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CHB, twice per month. The most recent reporting period available is January, 31 2024.